首页> 外文期刊>Chemical and Pharmaceutical Bulletin >Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities
【24h】

Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities

机译:肉桂酸的酰胺和酯衍生物的合成及其类似物:自由基清除和单胺氧化酶和胆碱酯酶抑制活性的评价

获取原文
获取原文并翻译 | 示例
           

摘要

A series of cinnamic acid derivatives, amides (1-12) and esters (13-22), were synthesized, and structure-activity relationships for antioxidant activity, and monoamine oxidases (MAO) A and B, acetylcholinesterase, and butyrylcholinesterase (BChE) inhibitory activities were analyzed. Among the synthesized compounds, compounds 1-10, 12-18, and rosmarinic acid (23), which contained catechol, o-methoxyphenol or 5-hydroxyindole moieties, showed potent 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging activity. Compounds 9-11, 15, 17-22 showed potent and selective MAO-B inhibitory activity. Compound 20 was the most potent inhibitor of MAO-B. Compounds 18 and 21 showed moderate BChE inhibitory activity. In addition, compound 18 showed potent antioxidant activity and MAO-B inhibitory activity. In a comparison of the cinnamic acid amides and esters, the amides exhibited more potent DPPH free radical scavenging activity, while the esters showed stronger inhibitory activities against MAO-B and BChE. These results suggested that cinnamic acid derivatives such as compound 18, p-coumaric acid 3,4-dihydroxyphenethyl ester, and compound 20, p-coumaric acid phenethyl ester, may serve as lead compounds for the development of novel MAO-B inhibitors and candidate lead compounds for the prevention or treatment of Alzheimer's disease.
机译:合成一系列肉桂酸衍生物,酰胺(1-12)和酯(13-22),以及用于抗氧化活性的结构 - 活性关系,单胺氧化酶(MAO)A和B,乙酰胆碱酯酶和丁酰胆碱酯酶(BCHE)分析了抑制活动。在合成化合物中,化合物1-10,12-18和罗哌啶酸(23),其含有儿茶酚,O-甲氧基苯酚或5-羟基吲哚部分,显示出有效的1,1-二苯基-2-富铬(DPPH)自由基清除活动。化合物9-11,15,15,15,17-22显示出有效和选择性的MaO-B抑制活性。化合物20是MAO-B最有效的抑制剂。化合物18和21显示了中等的BCHE抑制活性。此外,化合物18显示出有效的抗氧化活性和MAO-B抑制活性。在肉桂酸酰胺和酯的比较中,酰胺表现出更有效的DPPH自由基清除活性,而酯呈对MAO-B和BCHE的抑制活性较强。这些结果表明,肉桂酸衍生物如化合物18,p-香豆酸3,4-二羟基乙基酯和化合物20,化合物20,对香豆酸苯乙烷酯,可用作新型MAO-B抑制剂和候选者的铅化合物用于预防或治疗阿尔茨海默病的铅化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号